Good Medicine Podcast

On this episode of Good Medicine, Dr. David Bearss sits down with his brother Jeremiah for a raw and insightful conversation about obesity, weight loss, and the explosive rise of GLP-1 drugs.Together, they explore:The personal and societal toll of obesityHow GLP-1 medications are reshaping the weight loss landscapeThe science behind these treatments — and the hypeWhy lifestyle still matters, even in a pharmaceutical eraSubscribe for more real, honest conversations about health, innovation, and the future of medicine.

Thank you to our sponsors

BioHive: https://www.biohive.com

Galvan: https://galvan.sng.link/D4mh8/oe8k/litt

Follow Good Medicine Podcast

Insta: ⁠https://www.instagram.com/good.medicine.podcast/⁠ X: ⁠https://x.com/GoodMedicinePod⁠

TikTok: ⁠https://www.tiktok.com/@good.medicine.podcast⁠ LinkedIn: ⁠https://www.linkedin.com/company/goodmedicinepodcast/⁠

This week on Good Medicine, we sit down with Henry O’Connell, CEO of Canary Speech, a company using vocal biomarkers to revolutionize mental and neurological health diagnostics.

With a career spanning leadership roles at NIH, HP, and MOXTEK, Henry brings decades of insight into how technology can transform healthcare. In this episode, he explains how Canary’s voice analysis tools are giving doctors a clearer picture of patient health, removing global bias from diagnostics, and helping parents better support their kids’ emotional well-being.

🔍 We explore:

• How vocal data can complement traditional medical tools

• The role of AI in detecting mental health conditions

• Making healthcare more equitable across cultures and regions

• Empowering parents with real-time emotional insights

Whether you're a clinician, innovator, or just curious about the future of healthcare, this conversation offers a fascinating look at how something as simple as your voice could shape the next era of medicine.

Thank you to our sponsors

BioHive: https://www.biohive.com

Galvan: https://galvan.sng.link/D4mh8/oe8k/littFollow

Good Medicine Podcast

Insta: ⁠https://www.instagram.com/good.medicine.podcast/⁠ X: ⁠https://x.com/GoodMedicinePod⁠

TikTok: ⁠https://www.tiktok.com/@good.medicine.podcast⁠ LinkedIn: ⁠https://www.linkedin.com/company/goodmedicinepodcast/⁠

In this episode of Good Medicine, David Bearss sits down with John Lippert, founder and Chief Technology Officer at Scientia. With a career spanning decades in the medical device industry, John shares insights from his work in neurovascular innovation, startup leadership, and the evolution of less-invasive medicine. As the founder of both Scientia Vascular and Precision Vascular Systems—and with a background at leading companies like Target Therapeutics and Advanced Cardiovascular Systems—John brings a rare depth of technical expertise and entrepreneurial vision.We explore his impressive portfolio of patents, his approach to building breakthrough technologies, and the values that have guided his journey from engineer to industry leader.Thank you to our sponsorsBioHive: https://www.biohive.comGalvan: https://galvan.sng.link/D4mh8/oe8k/littFollow Good Medicine PodcastInsta: ⁠https://www.instagram.com/good.medicine.podcast/⁠ X: ⁠https://x.com/GoodMedicinePod⁠ TikTok: ⁠https://www.tiktok.com/@good.medicine.podcast⁠ LinkedIn: ⁠https://www.linkedin.com/company/goodmedicinepodcast/⁠

In this episode of Good Medicine, Dr. Bearss sits down with Mark Paul, a veteran of the medical device industry, to explore the intersection of innovation, engineering, and patient care.Mark shares lessons from a decades-long career — from early product development to scaling companies that have improved countless lives. He reflects on the mindset needed to lead teams, solve real-world problems, and bring new devices to market. It's a rare look behind the curtain of medtech from someone who’s lived it.Whether you're an engineer, healthcare investor, startup founder, or just fascinated by the tools that keep people alive and thriving, this is an episode packed with insight and inspiration.Thank you to our sponsorsBioHive: https://www.biohive.comGalvan: https://galvan.sng.link/D4mh8/oe8k/littFollow Good Medicine PodcastInsta: ⁠https://www.instagram.com/good.medicine.podcast/⁠ X: ⁠https://x.com/GoodMedicinePod⁠ TikTok: ⁠https://www.tiktok.com/@good.medicine.podcast⁠ LinkedIn: ⁠https://www.linkedin.com/company/goodmedicinepodcast/⁠

This week on Good Medicine, Dr. David Bearss dives into the roles of the FDA and NIH in today’s healthcare landscape. He explores the vital impact these institutions have on innovation, safety, and public trust—while also examining the growing debates around how they operate. From differing perspectives across industry, academia, and government, Dave unpacks the complex views on what should evolve and why it matters.

Whether you're in biotech, policy, or just curious about the forces shaping medicine, this episode offers a grounded, insightful look at two of the most influential organizations in health.

SponsorsBioHive: ⁠https://www.biohive.comGalvan: https://www.galvan.healthFollow Good Medicine PodcastInsta: ⁠https://www.instagram.com/good.medicine.podcast/⁠ X: ⁠https://x.com/GoodMedicinePodTikTok: ⁠https://www.tiktok.com/@good.medicine.podcastLinkedIn: ⁠https://www.linkedin.com/company/goodmedicinepodcast/

In this episode of Good Medicine, Dr. Bearss sits down with Dr. Ryan Watts, CEO of Denali Therapeutics, to explore the cutting edge of neurodegenerative disease research.

They dive deep into the science behind treating Alzheimer’s, Parkinson’s, ALS, and other brain disorders — including how Denali is tackling one of the biggest challenges in medicine: getting therapies across the blood-brain barrier.

Topics include:- Why the brain is uniquely hard to treat- How genetics and biomarkers are shaping drug development- Denali’s approach to targeted therapeutics and clinical trials- The future of neuroscience and precision medicine

Whether you’re a scientist, student, investor, or just curious about how modern biotech is taking on brain disease, this is a conversation you don’t want to miss.

Sponsors

BioHive: ⁠https://www.biohive.com/⁠

Galvan: https://www.galvan.health/

Follow Good Medicine Podcast

Insta: ⁠https://www.instagram.com/good.medicine.podcast/⁠ X: ⁠https://x.com/GoodMedicinePod⁠

TikTok: ⁠https://www.tiktok.com/@good.medicine.podcast⁠ LinkedIn: ⁠https://www.linkedin.com/company/goodmedicinepodcast/⁠

In this solo episode, Dr. Bearss breaks down the controversial “Most Favored Nation” (MFN) drug pricing rule introduced during the Trump administration. What is the policy aiming to solve? How would it change the cost of prescription drugs in the U.S.? And why did it stir such intense debate across the healthcare and pharmaceutical industries?

With clear, research-backed insight, David explores the economic and political implications of MFN, how it compares to international drug pricing models, and what it tells us about the future of healthcare reform in America.

Whether you’re in healthcare, policy, or just trying to make sense of why your prescriptions cost so much, this is a must-listen.

Sponsors

BioHive: ⁠https://www.biohive.com/⁠

Galvan: https://www.galvan.health/

Follow Good Medicine Podcast

Insta: ⁠https://www.instagram.com/good.medicine.podcast/⁠ X: ⁠https://x.com/GoodMedicinePod⁠

TikTok: ⁠https://www.tiktok.com/@good.medicine.podcast⁠ LinkedIn: https://www.linkedin.com/company/goodmedicinepodcast/⁠

In this episode of the podcast, Dr. David Bearss sits down with Dr. Chris Gibson, Co-Founder and CEO of Recursion.

Dr. Gibson shares his journey from graduate research at the University of Utah to building Recursion into one of the most advanced AI-driven drug discovery companies in the world. They discuss the intersection of biology and machine learning, the future of drug development, and how Recursion is leveraging massive proprietary datasets and the most powerful supercomputer in pharma to reshape the healthcare landscape.

Sponsors

BioHive: ⁠https://www.biohive.com/⁠

Galvan: https://www.galvan.health/

Follow Good Medicine Podcast

Insta: ⁠https://www.instagram.com/good.medicine.podcast/⁠ X: ⁠https://x.com/GoodMedicinePod⁠

TikTok: ⁠https://www.tiktok.com/@good.medicine.podcast⁠ LinkedIn:https://www.linkedin.com/company/goodmedicinepodcast/⁠

In this special episode of the Good Medicine Podcast, Kelvyn Cullimore sits down with Dr. David Bearss for a wide-ranging conversation that gives listeners a chance to get to know the voice behind the mic.

From his early life and scientific journey to what motivates his work today, Dr. Bearss opens up about his path, passions, and perspective on the future of healthcare and innovation.

🎧 Tune in to hear the story behind the scientist — and the heart behind the mission.

Sponsors

BioHive: ⁠https://www.biohive.com/⁠ Galvan: https://www.galvan.health/

Follow Good Medicine Podcast

Insta: ⁠https://www.instagram.com/good.medicine.podcast/⁠

X: ⁠https://x.com/GoodMedicinePod⁠

TikTok: ⁠https://www.tiktok.com/@good.medicine.podcast⁠

LinkedIn:

⁠https://www.linkedin.com/company/goodmedicinepodcast/⁠

On this episode of the Good MedicinePodcast, we discuss why drugs are so expensive. We break down the complex world of drug pricing—from research and development costs to patent protections, insurance dynamics, and the roles of pharmaceutical companies and middlemen.

Whether you’re a curious patient, healthcare professional, or just wondering why your prescriptions keep getting more expensive, this episode will help you understand the real reasons behind rising drug prices—and what could be done to fix it.

Sponsors

BioHive: https://www.biohive.com/

Galvan: https://www.galvan.health/

Follow Good Medicine Podcast

Insta: https://www.instagram.com/good.medicine.podcast/

X: https://x.com/GoodMedicinePod

TikTok: https://www.tiktok.com/@good.medicine.podcast

LinkedIn: https://www.linkedin.com/company/goodmedicinepodcast/